Results 91 to 100 of about 6,429 (163)

Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

Journal for ImmunoTherapy of Cancer
Cytokines are small proteins that regulate the growth and functional activity of immune cells, and several have been approved for cancer therapy. Oncolytic viruses are agents that mediate antitumor activity by directly killing tumor cells and inducing ...
Howard L Kaufman, Hongbin Wang, Dipongkor Saha, Samuel D Rabkin, Mia Borlongan, Uyen Le, Hans J Nauwynck   +6 more
doaj   +1 more source

Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity. [PDF]

Mol Ther Oncolytics, 2023
Xie J, Wang S, Zhong Y, Gao M, Tian X, Zhang L, Pan D, Qin Q, Wu B, Lan K, Sun ZJ, Zhang J.   +11 more
europepmc   +1 more source

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

Journal of Hepatocellular Carcinoma, 2014
Lynne Braidwood, Kirsty Learmonth, Alex Graham, Joe Conner Virttu Biologics Ltd, Department of Neurology, Southern General Hospital, Glasgow, UK Abstract: Oncolytic herpes simplex virus (HSV1716), lacking the neurovirulence factor ICP34.5, has highly ...
Braidwood L, Learmonth K, Graham A, Conner J   +3 more
doaj  

Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells. [PDF]

Vaccines (Basel), 2023
Delwar Z, Tatsiy O, Chouljenko DV, Lee IF, Liu G, Liu X, Bu L, Ding J, Singh M, Murad YM, Jia WW.   +10 more
europepmc   +1 more source

Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma. [PDF]

Biomed Pharmacother, 2022
Kawamura Y, Hua L, Gurtner A, Wong E, Kiyokawa J, Shah N, Gorham J, Wakimoto H, Rabkin SD, Martuza RL, Wakimoto H.   +10 more
europepmc   +1 more source

Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer. [PDF]

Int J Mol Sci, 2023
Reale A, Krutzke L, Cadamuro M, Vitiello A, von Einem J, Kochanek S, Palù G, Parolin C, Calistri A.   +8 more
europepmc   +1 more source

Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor. [PDF]

Int J Mol Sci, 2023
Kagabu M, Yoshino N, Murakami K, Kawamura H, Sasaki Y, Muraki Y, Baba T.   +6 more
europepmc   +1 more source

Oncolytic herpes simplex virus (HSV) strains [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Construction of an IL12 and CXCL11 armed oncolytic herpes simplex virus using the CRISPR/Cas9 system for colon cancer treatment. [PDF]

Virus Res, 2023
Zhang N, Li J, Yu J, Wan Y, Zhang C, Zhang H, Cao Y.   +6 more
europepmc   +1 more source